European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis
about
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysisThe Role of Laboratory Tests in Crohn's DiseaseEndoscopic Diagnosis and Differentiation of Inflammatory Bowel DiseaseCharacterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysisInfliximab induces clonal expansion of γδ-T cells in Crohn's disease: a predictor of lymphoma risk?Cognitive behavioural therapy for the management of inflammatory bowel disease-fatigue with a nested qualitative element: study protocol for a randomised controlled trial.Contrast Enhanced Abdominal Ultrasound in the Assessment of Ileal Inflammation in Crohn's Disease: A Comparison with MR Enterography.Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial).Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding studyFrequency and nature of incidental extra-enteric lesions found on magnetic resonance enterography (MR-E) in patients with inflammatory bowel diseases (IBD).The diagnosis and treatment of Crohn's disease and ulcerative colitisAnti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?Leukocyte-technetium-99m uptake in Crohn's disease: does it show subclinical disease?Follow-up endoscopy in gastroenterology: when is it helpful?Inflammatory bowel disease in the dog: differences and similarities with humans.Fluorescent quantitative PCR of Mycobacterium tuberculosis for differentiating intestinal tuberculosis from Crohn's disease.Assessment of Crohn's disease activity by Doppler sonography.Clinical epidemiology and phenotypic characteristics of Crohn's disease in the central region of Saudi Arabia.Long-term follow-up of nonspecific small bowel ulcers with a benign course and no requirement for surgery: is this a distinct group?Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey.Divergent neuroendocrine responses to localized and systemic inflammation.The association between race and Crohn's disease phenotype in the Western Cape population of South Africa, defined by the Montreal Classification SystemNutrient intake and bone mineral density by nutritional status in patients with inflammatory bowel disease.Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition.Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.Magnetic resonance enterography in Crohn's disease: Standard and advanced techniques.Anti-cyclic citrullinated peptide antibodies in ulcerative colitis, and its relation with disease activity.Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's diseaseGuidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases.The association between childhood environmental exposures and the subsequent development of Crohn's disease in the Western Cape, South Africa.Inflammatory bowel disease unclassified.New biologics in the management of Crohn's disease: focus on certolizumab pegol.Dental caries, prevalence and risk factors in patients with Crohn's disease.Fecal Calprotectin is an Accurate Tool and Correlated to Seo Index in Prediction of Relapse in Iranian Patients With Ulcerative Colitis.Current treatment of ulcerative colitisAssessing patients' satisfaction with anti-TNFα treatment in Crohn's disease: qualitative steps of the development of a new questionnaire.Epstein-Barr virus is related with 5-aminosalicylic acid, tonsillectomy, and CD19(+) cells in Crohn's disease.Vitamin D status in children and young adults with inflammatory bowel disease.Association between toll-like receptors/CD14 gene polymorphisms and inflammatory bowel disease in Korean populationAdvances in the Endoscopic Assessment of Inflammatory Bowel Diseases: Cooperation between Endoscopic and Pathologic Evaluations.
P2860
Q24608254-361DC089-DD18-48AC-AD0A-AAFAD4BA9350Q28075045-382645A7-79BF-442B-8C33-99A13F92690FQ28078800-F6F2F8BF-F74A-462C-9860-F02EECB9D4D7Q28740412-FAE3B60A-38E0-40B3-9A1F-F34E292BF90FQ28741471-C21B29D3-38FE-43A9-8FDA-1AC65ED19EF7Q29994702-37D0DE6F-2CB4-4511-94C4-0DAF829895C8Q30403217-09A8EE30-869D-4362-9A18-91FFCCAAA150Q33362566-39C3C53F-A69D-4BE6-BCAC-FE2417AB3AAEQ33420096-7B639B76-0022-4F61-86D2-1C165138681DQ33425208-349CBD3B-B26E-4FDD-9259-2BDE8E4E6C09Q33476811-B4922B91-42CA-480B-91DC-787BC18EB9D6Q33564081-641DCF60-C401-4A2C-B67A-E2B7407686C1Q33596537-C31A25EC-7EE1-4E7B-A9BC-1752E39362ECQ33631352-D4372F67-5DB1-4CB3-BE05-4725FBC2962CQ33716262-F39F52B3-834F-4E79-BE19-1896DF732A21Q33732284-727FFECE-2606-4B34-B83B-497D3EB9503DQ33735242-27B2A9E2-7580-4A00-A129-C37AC89E7E0FQ33796025-D76E8590-6C7E-4D42-A9E6-5CB96C60B7B2Q33898431-51E42829-AF4A-45CB-A270-8D11C4155A1DQ33933336-FC1DE4F1-0F67-4678-BBAC-D510FA08EDF9Q34028610-4CA42A31-C739-4154-B6D4-311832EE19A4Q34035520-7161C80E-314D-475E-8308-5E1060711572Q34219185-572A6C2B-E684-4160-8ED9-3454A10D4167Q34311640-6FC7A264-0ADF-4038-B70D-66111309E753Q34367414-465F3D79-7C50-4A0F-821E-C65DD062A634Q34391707-E29EB7D0-9A9C-447E-9587-2634BD07B001Q34451163-6D08F120-8F74-4B98-8CE1-ADAE6B13C208Q34610205-1019D670-8D60-4200-97AA-14EC007ED722Q34710712-042A2076-5F0A-44B8-885B-7C60CA0AD3C2Q34713219-44BC17EF-BB10-4C98-9ACF-674A83537D6CQ34771646-861DAE20-086E-4E6E-8EC9-36D752B73B01Q35026264-00CF99D1-70DE-4C3C-8DA2-E1D783AAE774Q35114618-54FBAB11-D512-4A45-A0A2-B753A0E8B7A9Q35157904-6D7E8BE0-A3A9-4401-AC4D-684200502560Q35171533-F575F4C4-246D-4193-8D7D-3986299E787FQ35186984-B1FBFC58-84FD-42D7-8681-A662C53E958BQ35473146-77D990E3-ADD4-4788-9F6E-E3499C25EEA6Q35492283-F0CF9757-801F-4C0F-AD1C-CE1351F382FCQ35639054-AF7EFA3F-A983-4479-A07C-C59F5E0C20C6Q35643966-3CE49304-FC94-44DC-8DC3-C81878CA7E39
P2860
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
European evidence based consen ...... ase: definitions and diagnosis
@ast
European evidence based consen ...... ase: definitions and diagnosis
@en
type
label
European evidence based consen ...... ase: definitions and diagnosis
@ast
European evidence based consen ...... ase: definitions and diagnosis
@en
prefLabel
European evidence based consen ...... ase: definitions and diagnosis
@ast
European evidence based consen ...... ase: definitions and diagnosis
@en
P2093
P2860
P356
P1433
P1476
European evidence based consen ...... ase: definitions and diagnosis
@en
P2093
A Barakauskiene
A Von Herbay
B F Warren
C Beglinger
E F Stange
European Crohn's and Colitis Organisation
J Schölmerich
L Kupcinkas
P2860
P356
10.1136/GUT.2005.081950A
P407
P478
55 Suppl 1
P577
2006-03-01T00:00:00Z